Saratov JOURNAL of Medical and Scientific Research

Neurofibromatosis in the practice of dermatology

Year: 2018, volume 14 Issue: №4 Pages: 760-763
Heading: Dermatovenerology Article type: Case report
Authors: Slesarenko N.A., Morrison A.V., Marchenko V.M., Moiseev A.A., Sherstobitova K.Yu., Ishmukhametova R.A.
Organization: Saratov State Medical University

Neurofibromatosis belongs to the group of systemic hereditary diseases from the group of phakomatosis, characterized by developmental defects of ectodermal and mesodermal structures, mainly of the skin, nervous and bone systems, with an increased risk of developing malignant tumors. There are 7 types of the disease include a wide range of clinical manifestations even within the same family: a progressive course, the involvement of almost all organs and systems in the process, a high risk of complications, including many serious and fatal (cardiovascular) pulmonary insufficiency due to severe skeletal abnormalities, malignant degeneration by neurofibromas, etc.). An analysis of 5 clinical cases with neurofibromatosis is presented.

1 Butov YuS, Skripkina YuK, Ivanova OL. Dermatovenere-ology: National guide, short edition. Moscow, 2013; p. 836-41
2 Schnayder NA, Shapovalova ЕА. Clinical observation of late diagnosis of Recklinghausen's disease in an 18-year- old boy. International Neurological Journal 2011; (1): 25-7
3 Macurdumyan LA. The effectiveness of the complex method of treatment of patients with type 1 neuro- fibromatosis: PhD diss. Moscow, 2003; 97 p.
4 Sakhanova ASh, Kenjebaeva КА, Babiy D, et al. Neu-rofibromatosis in children. Kazakhstan: Karaganda State Medical University, 2017; p. 47-52
5 Suvorov АР, Orkin VF, Zavyalov Al, et al. Family case of Recklinghausen's disease. Russian Journal of Skin and Venereal Diseases 2001; (3): 31-2
6 Shporta TYu. Neurofibromatosis on the example of the study of the central nervous system. URL: 2 .pd f.

2018_4-1_760-763.pdf1.61 MB

No votes yet